Automated Insulin Delivery System Market Research Report by Disease Type (Type I Diabetes and Type II Diabetes), by Distribution (Diabetes Clinics, Hospital Pharmacies, and Retail Pharmacies) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Automated Insulin Delivery System Market is expected to grow from USD 626.16 Million in 2020 to USD 952.86 Million by the end of 2025.
2. The Global Automated Insulin Delivery System Market is expected to grow from EUR 549.03 Million in 2020 to EUR 835.49 Million by the end of 2025.
3. The Global Automated Insulin Delivery System Market is expected to grow from GBP 488.09 Million in 2020 to GBP 742.75 Million by the end of 2025.
4. The Global Automated Insulin Delivery System Market is expected to grow from JPY 66,828.08 Million in 2020 to JPY 101,694.84 Million by the end of 2025.
5. The Global Automated Insulin Delivery System Market is expected to grow from AUD 909.28 Million in 2020 to AUD 1,383.68 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Automated Insulin Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Disease Type, the Automated Insulin Delivery System Market studied across Type I Diabetes and Type II Diabetes.
Based on Distribution, the Automated Insulin Delivery System Market studied across Diabetes Clinics, Hospital Pharmacies, and Retail Pharmacies.
Based on Geography, the Automated Insulin Delivery System Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Automated Insulin Delivery System Market including Abbott Laboratories, Bigfoot Biomedical Inc., Dexcom, Inc., Diabeloop SA, DreaMed Diabetes, Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Tandem Diabetes Care, Inc., and Ypsomed Holding AG.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Automated Insulin Delivery System Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Automated Insulin Delivery System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Automated Insulin Delivery System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Automated Insulin Delivery System Market?
4. What is the competitive strategic window for opportunities in the Global Automated Insulin Delivery System Market?
5. What are the technology trends and regulatory frameworks in the Global Automated Insulin Delivery System Market?
6. What are the modes and strategic moves considered suitable for entering the Global Automated Insulin Delivery System Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Automated Insulin Delivery System Market is expected to grow from USD 626.16 Million in 2020 to USD 952.86 Million by the end of 2025.
2. The Global Automated Insulin Delivery System Market is expected to grow from EUR 549.03 Million in 2020 to EUR 835.49 Million by the end of 2025.
3. The Global Automated Insulin Delivery System Market is expected to grow from GBP 488.09 Million in 2020 to GBP 742.75 Million by the end of 2025.
4. The Global Automated Insulin Delivery System Market is expected to grow from JPY 66,828.08 Million in 2020 to JPY 101,694.84 Million by the end of 2025.
5. The Global Automated Insulin Delivery System Market is expected to grow from AUD 909.28 Million in 2020 to AUD 1,383.68 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Automated Insulin Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Disease Type, the Automated Insulin Delivery System Market studied across Type I Diabetes and Type II Diabetes.
Based on Distribution, the Automated Insulin Delivery System Market studied across Diabetes Clinics, Hospital Pharmacies, and Retail Pharmacies.
Based on Geography, the Automated Insulin Delivery System Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Automated Insulin Delivery System Market including Abbott Laboratories, Bigfoot Biomedical Inc., Dexcom, Inc., Diabeloop SA, DreaMed Diabetes, Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Tandem Diabetes Care, Inc., and Ypsomed Holding AG.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Automated Insulin Delivery System Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Automated Insulin Delivery System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Automated Insulin Delivery System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Automated Insulin Delivery System Market?
4. What is the competitive strategic window for opportunities in the Global Automated Insulin Delivery System Market?
5. What are the technology trends and regulatory frameworks in the Global Automated Insulin Delivery System Market?
6. What are the modes and strategic moves considered suitable for entering the Global Automated Insulin Delivery System Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Disease Type Outlook
3.4. Distribution Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diabetes
5.1.1.2. Increasing awareness campaigns
5.1.2. Restraints
5.1.2.1. Difficulties with the calibration of a glucose sensor, sensor durability, skin-related issues
5.1.3. Opportunities
5.1.3.1. Increasing R&D activities for the production of innovative insulin delivery systems
5.1.3.2. Mild regulatory approval and technical clarity for the use of devices among people
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, BY DISEASE TYPE
6.1. Introduction
6.2. Type I Diabetes
6.3. Type II Diabetes
7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, BY DISTRIBUTION
7.1. Introduction
7.2. Diabetes Clinics
7.3. Hospital Pharmacies
7.4. Retail Pharmacies
8. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. Bigfoot Biomedical Inc.
12.3. Dexcom, Inc.
12.4. Diabeloop SA
12.5. DreaMed Diabetes, Ltd.
12.6. Eli Lilly and Company
12.7. F. Hoffmann-La Roche Ltd
12.8. Insulet Corporation
12.9. Medtronic PLC
12.10. Novo Nordisk A/S
12.11. Tandem Diabetes Care, Inc.
12.12. Ypsomed Holding AG
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Disease Type Outlook
3.4. Distribution Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diabetes
5.1.1.2. Increasing awareness campaigns
5.1.2. Restraints
5.1.2.1. Difficulties with the calibration of a glucose sensor, sensor durability, skin-related issues
5.1.3. Opportunities
5.1.3.1. Increasing R&D activities for the production of innovative insulin delivery systems
5.1.3.2. Mild regulatory approval and technical clarity for the use of devices among people
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, BY DISEASE TYPE
6.1. Introduction
6.2. Type I Diabetes
6.3. Type II Diabetes
7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, BY DISTRIBUTION
7.1. Introduction
7.2. Diabetes Clinics
7.3. Hospital Pharmacies
7.4. Retail Pharmacies
8. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. Bigfoot Biomedical Inc.
12.3. Dexcom, Inc.
12.4. Diabeloop SA
12.5. DreaMed Diabetes, Ltd.
12.6. Eli Lilly and Company
12.7. F. Hoffmann-La Roche Ltd
12.8. Insulet Corporation
12.9. Medtronic PLC
12.10. Novo Nordisk A/S
12.11. Tandem Diabetes Care, Inc.
12.12. Ypsomed Holding AG
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: SCORES
TABLE 71. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: BUSINESS STRATEGY
TABLE 72. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 73. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: RANKING
TABLE 74. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: MERGER & ACQUISITION
TABLE 75. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 76. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 77. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 78. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 79. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: SCORES
TABLE 71. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: BUSINESS STRATEGY
TABLE 72. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 73. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: RANKING
TABLE 74. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: MERGER & ACQUISITION
TABLE 75. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 76. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 77. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 78. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 79. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2025
FIGURE 16. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (%)
FIGURE 19. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2025
FIGURE 21. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 24. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 25. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 27. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 47. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 59. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 60. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 61. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, BY TYPE
FIGURE 1. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2025
FIGURE 16. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (%)
FIGURE 19. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2025
FIGURE 21. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 24. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 25. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 27. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 47. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 59. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 60. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 61. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, BY TYPE
